Clinical trial Recruiting at 1 site Interventional Ages 8 to 12

Regulating Together for Emotion Dysregulation in ASD and Intellectual Disability (group therapy)

Official title: Adapting a Group Intervention for Emotion Dysregulation in Autism and Intellectual Disability

Run by Children's Mercy Hospital Kansas City · NCT07624448 · Data updated 2026-11-12

This study tests a group therapy program for kids with autism and co-occurring intellectual disability to help them manage irritability and aggression, with sessions for both children and their caregivers.

Quick facts

Study typeInterventional
Ages8 Years to 12 Years
SexAll
Enrollment10 (estimated)
SponsorChildren's Mercy Hospital Kansas City
Academic / other
Locations1 site (Kansas City, Missouri)
StatusRecruiting
StartedOctober 2027
Main results expectedJune 2028
Study endsAugust 2028
Registry record updatedSeptember 3, 2026
Trial IDNCT07624448 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 8–12 with ASD and intellectual disability who have clinically significant emotion dysregulation and whose families are able to participate in twice-weekly sessions for 5 weeks.

Probably not a fit

Participants with severe behavioral risk requiring more intensive intervention or those unable to engage in group sessions may see limited benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study adapts Regulating Together materials into an outpatient, group-based program for children with ASD and ID who have emotion dysregulation. Up to ten children aged 8–12 and their caregivers will participate in 5 weeks of twice-weekly, 90-minute sessions, with assessments at five time points (baseline, post-treatment, and follow-ups at weeks 10 and 15). The program aims to improve psychosocial outcomes by teaching emotion regulation strategies and monitoring changes over time. Safety and eligibility criteria ensure participants have diagnosed ASD and ID, English fluency, and willingness to maintain stable medications and outside therapies during the study.

Why it matters

Potential benefit: If successful, participants may show reduced irritability and improved emotion regulation and social functioning.

How similar studies have gone: Previous research on Regulating Together-like approaches suggests potential benefits for emotion regulation in related populations, but this specific ASD+ID group therapy approach is being explored.

Who can join: the full rules

Show full inclusion / exclusion criteria
Child Participant Inclusion Criteria:

* Males, females, or non-binary youth between 8 and 12 years of age
* Confirmed diagnosis of Autism Spectrum Disorder (ASD)
* Confirmed diagnosis of Intellectual Disability
* Fluent in spoken English.
* Use of flexible phrase speech or greater
* Meeting clinically significant emotion dysregulation criteria
* Willing to participate in twice weekly 90-minute sessions
* Family is willing to keep prescribed psychiatric medication and outside behavioral interventions stable
* Parent, guardian, or legally authorized representative (LAR) must provide written permission on behalf of the participant

Child Participant Exclusion Criteria:

* Initiation of new psychosocial intervention within 30 days prior to first day of treatment
* Presence of physical aggression in the child directed towards a peer outside the home (i.e., non-siblings) that resulted in injury within 30 days prior to screening. Other significant disruptive, aggressive, self-injurious, or sexually inappropriate behavior felt to be dangerous or overly disruptive to the group sessions will be reviewed by the study team on an individual basis.
* Presence of comorbid major neuropsychiatric illness warranting other treatment approaches
* Presence of any major sensory impairment that would limit participating in the material including blindness or uncorrected hearing loss

Caregiver Inclusion Criteria:

* Age ≥ 18 years
* Lives and cares for their child with ASD+ID for \> 50% of the year
* Fluent in spoken English.
* Willing to participate in twice weekly 90-minute sessions, including one virtual session weekly

Caregiver Exclusion Criteria:

-Presence of any major sensory impairment that would limit participating in the material including blindness or uncorrected hearing loss

Where it's running

  • Children's Mercy
    Kansas City, Missouri, United States
    Recruiting

Study contacts

  • Principal investigator: Walker McKinney, PhD — Children's Mercy
  • Study coordinator: Grayson Manley, RN
  • Email: gmanley@cmh.edu
  • Phone: 816-816-6967

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.